All posts tagged "You need to guide the approval process — experts"

New Alzheimer’s Disease Drugs — Science Should Lead Approval, Not Despair: Experts

Aducanumab, a drug for Alzheimer’s disease, is being considered by the Therapeutic Products Administration, but the author of the outlook is Medical Journal of Australia “Science,...